Veracyte logo

Veracyte Funding & Investors

Veracyte, Inc. develops molecular tests for oncology. The Company offers molecular cytology and tests for the diagnostic accuracy of cytology samples. Veracyte provides its products and services to healthcare and molecular diagnostic companies in the United States.

https://www.veracyte.com/

Total Amount Raised: $1,098,150,016

Veracyte Funding Rounds

  • Post Ipo Equity

    $550,000,000

  • Post Ipo Equity

    $194,000,000

  • Post Ipo Equity

    $137,800,000

  • Post Ipo Equity

    $55,100,000

  • Post Ipo Equity

    $30,000,000

  • Post Ipo Debt

    $45,000,000

    Post Ipo Debt Investors

    Madryn Health Partners
  • Debt Financing

    $15,000,000

    Debt Financing Investors

    Armentum Partners
  • Series C

    $28,000,000

    Series C Investors

    GE Ventures
    Kleiner Perkins
    TPG Biotech
    Domain Associates
    Versant Ventures
  • Series Unknown

    $14,950,000

    Series Unknown Investors

    Domain Associates
    Kleiner Perkins
  • Series B

    $28,000,000

    Series B Investors

    Domain Associates
    TPG Biotech
    Kleiner Perkins
    Versant Ventures
  • Series A

    $300,000

  • IPO

    Unknown

Funding info provided by Diffbot.